Merck beats Q1 forecasts, helped by Januvia, animal health brands

April 28 (Reuters) - Merck & Co reported better than expected quarterly sales and earnings, helped by sales of its Januvia diabetes drug and its animal health products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.